Related Experiment Video
Updated: Aug 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Ocular hypertension and secondary glaucoma in children with uveitis
Karen M Sijssens1, Aniki Rothova, Tos T J M Berendschot
1FC Donders Institute of Ophthalmology, University Medical Center, Utrecht, The Netherlands. k.sijssens@oogh.azu.nl
Insights
Pediatric uveitis increases the risk of ocular hypertension and secondary glaucoma. Juvenile idiopathic arthritis-associated uveitis and antinuclear antibody-positive uveitis are key risk factors for developing glaucoma.
Area of Science:
- Ophthalmology
- Pediatric Rheumatology
- Immunology
Background:
- Uveitis in children can lead to serious complications like ocular hypertension and secondary glaucoma.
- Early identification of risk factors is crucial for managing pediatric uveitis and preventing vision loss.
Purpose of the Study:
- To identify risk factors for ocular hypertension and secondary glaucoma in children diagnosed with uveitis before age 16.
- To analyze the association between uveitis characteristics, systemic diseases, and glaucoma development.
Main Methods:
- Retrospective observational case series analyzing 147 children's medical records (256 eyes).
- Data collected included uveitis type, course, systemic associations, antinuclear antibody (ANA) status, steroid use, and glaucoma onset.
- Follow-up duration varied, with data spanning from 1990 to 2004.
Main Results:
- Elevated intraocular pressure (IOP) developed in 35% of pediatric uveitis cases within 5 years.
- Secondary glaucoma was more prevalent in juvenile idiopathic arthritis-associated uveitis (38%) and ANA-positive uveitis (42%).
- Two-thirds of children developed elevated IOP within 2 years of uveitis diagnosis; periocular steroids increased risk except in JIA-associated uveitis.
Conclusions:
- Juvenile idiopathic arthritis-associated uveitis is a significant risk factor for secondary glaucoma in children.
- ANA-positive uveitis, even without arthritis, is also a major risk factor for glaucoma development.
- Prompt monitoring and management are essential for children with these risk factors.
Purpose:
To identify the risk factors for ocular hypertension and secondary glaucoma in children with uveitis.
Design:
Retrospective observational case series of 147 patient records.
Participants:
Two hundred fifty-six eyes of 147 children with uveitis diagnosed before the age of 16 years.
Methods:
Data were obtained from the medical records of children with uveitis evaluated at our institute from 1990 through 2004.
Main Outcome Measures:
Localization and course of uveitis (acute or chronic), underlying systemic disease, onset of ocular hypertension, onset of secondary glaucoma, treatment with steroids, antinuclear antibodies (ANAs), lens extractions, number of blind eyes at onset and during follow-up, and the duration of follow-up.
Results:
Elevated intraocular pressure developed in 35% of children with pediatric uveitis regardless of the form or type of uveitis during a follow-up of 5 years. Secondary glaucoma, however, developed more frequently in juvenile idiopathic arthritis-associated uveitis (38%) compared with other forms of uveitis (11%) and more frequently in children with uveitis who were ANA positive (42%) than in those who were ANA negative (6%). Elevated intraocular pressure occurred in two thirds of all children within the first 2 years after the diagnosis of uveitis. Except for patients with juvenile idiopathic arthritis-associated uveitis, periocular steroid injections represented an additional risk factor for secondary glaucoma, but this risk was limited to the early phase of the disease process.
Conclusions:
In children with uveitis in this series, juvenile idiopathic arthritis-associated uveitis and ANA-positive uveitis without evidence of arthritis are the most important risk factors for developing secondary glaucoma.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways